OncoMed Pharmaceuticals, Inc.

Industry / private company


Location: Redwood City, CA

ISNI: 0000000404899295

ROR: https://ror.org/00g5dc702

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs (2020) Zhang M, Haughey M, Wang NY, Blease K, Kapoun AM, Couto S, Belka I, et al. Journal article